Professional Documents
Culture Documents
A
lcohol misuse is associated lead to missed information about medical
with considerable morbid- and psychiatric conditions, potential sur-
ity and mortality (100,000 gical complications, unexpected alcohol
deaths annually), social withdrawal symptoms, drug interactions,
and legal problems, acts of and lost opportunities for prevention,
violence, and accidents. Alcoholism is including intervention during pregnancy
among the most common psychiatric to prevent damaging effects of alcohol on
disorders in the general population: the the fetus. All too often, patients, particu-
lifetime prevalence of alcohol depen- larly the elderly, continue to be treated
dence, the severe form of alcoholism, is symptomatically for alcohol-related con-
8 to 14 percent.1 The ratio of alcohol ditions without recognition of the under-
dependence to alcohol abuse is approxi- lying problem (Table 1). There are many
mately two to one. The incidence of al- reasons why there is a worldwide ten-
coholism is still more common in men, dency for physicians to neglect or be un-
but it has been increasing in women, and aware of symptoms and signs of alcohol
the female to male ratio for alcohol abuse, but inappropriate attitudes, insuffi-
dependence has narrowed to one to two.2 cient medical school training in this sub-
Serious drinking often starts in adoles- ject, and subsequent low confidence to
cence; approximately 40 percent of alco- treat are key elements.
holics develop their first symptoms
between 15 and 19 years of age.3 Etiology
Alcoholism often goes undiagnosed; Alcoholism is familial; an important
the rate of screening for alcohol con- risk factor for developing the disease is to
sumption in health care settings remains have an alcoholic parent. Although envi-
lower than 50 percent.4 Some patients also ronmental and interpersonal factors are
may withhold information because of important, a genetic predisposition un-
shame or fear of stigmatization. This can derlies alcoholism, particularly in the
FEBRUARY 1, 2002 / VOLUME 65, NUMBER 3 www.aafp.org/afp AMERICAN FAMILY PHYSICIAN 441
TABLE 2
Elevated Laboratory Test Results
as Indicators of Alcohol Misuse
Symptoms Signs
TABLE 3
Recurrent intoxication, nausea, Heavy, regular alcohol consumption, heavy
sweating, tachycardia cigarette smoking U.S. Government Recommended ‘Safe’
Amnesic episodes (blackouts) Other substance abuse (e.g., cannabis, Levels for Alcohol Consumption
Mood swings, depression, cocaine, heroin, amphetamines, sedatives,
anxiety, insomnia, chronic hypnotics, and anxiolytics) Men: two drinks per day
fatigue Unexpected medication response (drug Women: one drink per day
Grand mal seizures, interactions) Standard drink (U.S.) = 12 g of alcohol:
hallucinations, delirium Poor nutrition and personal neglect one 12 oz bottle of beer (4.5 percent); or
tremens Frequent falls or minor trauma (particularly one 5 oz glass of wine (12.9 percent); or
Dyspepsia, diarrhea, bloating, in the elderly) 1.5 oz of 80-proof distilled spirits
hematemesis, jaundice Accidents, burns, violence, suicide
Tremor, unsteady gait, Recurrent absenteeism from work or school Information from 10th special report to U.S. Con-
paraesthesia, memory loss, Spontaneous abortion, child with fetal gress on alcohol and health: highlights from current
erectile dysfunction alcohol syndrome research from the Secretary of Health and Human
Increased vulnerability Services. U.S. Dept. of Health and Human Services,
Alcoholic parent, childhood conduct disorder, Public Health Service, National Institutes of Health.
antisocial personality disorder National Institute on Alcohol Abuse and Alcoholism
Negative life event 2000:429-30; NIH publication no. 00-1583.
442 AMERICAN FAMILY PHYSICIAN www.aafp.org/afp VOLUME 65, NUMBER 3 / FEBRUARY 1, 2002
Screening for Problem Drinking:
The Alcohol Use Disorders Identification Test (AUDIT)
FEBRUARY 1, 2002 / VOLUME 65, NUMBER 3 www.aafp.org/afp AMERICAN FAMILY PHYSICIAN 443
TABLE 4
Screening for Problem Drinking: Quantity/Frequency Questionnaire*
the most accurate test for identifying problem proved to be the superior instrument for
drinking (Figure 1).14 The AUDIT is used by detecting alcohol abuse and alcohol depen-
the NIAAA in the community for National dence (Table 5).16 The 10-question Brief
Alcohol Screening Day. If there is only time Michigan Alcoholism Screening Test
for a shorter screening instrument, the Quan- (BMAST) and the five-question TWEAK (Tol-
tity/Frequency Questionnaire15 devised by erance, Worry about drinking, Eye-opener
the NIAAA may be used (Table 4).15 Identi- drinks, Amnesia, Cut down on drinking K/C)
fied problem drinkers can then be further are also used reliably to detect alcoholism by
assessed for alcoholism. assessment of the patient’s, relatives’, and
The CAGE questionnaire has consistently friends’ attitudes to their drinking.12 Which-
ever questionnaire is used, lower thresholds for
a positive result should be used for women
TABLE 5 (Figure 1 and Table 5), because women experi-
Screening for Alcoholism: The CAGE ence harmful effects at lower levels of alcohol
Questionnaire* consumption than men.17
Treatment
The severity of the alcohol problem,
comorbid medical and psychosocial prob-
The rightsholder did not lems, and the patient’s motivation to change
grant rights to reproduce are key elements influencing the family physi-
this item in electronic cian’s choice of intervention.
media. For the missing
TREATMENT OF PROBLEM DRINKING
item, see the original print
version of this publication. Brief intervention is a short-term counseling
strategy based on motivational enhancement
therapy that concentrates on changing patient
behavior and increasing patient compliance
with therapy (Figure 2).18,19 It has been shown
to be effective for helping socially stable prob-
lem drinkers to reduce or stop drinking,19,20 for
motivating alcohol-dependent patients to
444 AMERICAN FAMILY PHYSICIAN www.aafp.org/afp VOLUME 65, NUMBER 3 / FEBRUARY 1, 2002
Key Elements of Effective Brief Intervention
for Problem Drinking in a Primary Health Care Setting
Session 1: Visit with physician, 15 minutes
1. Review quantity and frequency of current drinking.
2. Review personal drinking cues.
3. Give feedback of personal risk for alcohol-related problems.
4. Give explicit advice to reduce or stop drinking.
enter long-term alcohol treatment, and for 5. Discuss patient’s personal responsibility and choice for reducing
or stopping drinking.
treating some alcohol-dependent patients for
6. Find appropriate personal timing for change.
whom the goal is abstinence.21 Generally con-
7. Establish a drinking goal and agree on a contract.
ducted in four or fewer sessions, each lasting 8. Set up a drinking diary.
from a few minutes to an hour depending on 9. Suggest ways for behavior modification, coping techniques, and self-help
the severity of the patient’s alcohol problem, it materials.
is designed for health professionals who are 10. Encourage self-motivation and optimism.
not specialists in addiction (Figure 2).18,19 Session 2, two weeks later: Clinic nurse, via telephone
Follow-up and reinforcement
TREATMENT OF ALCOHOL DEPENDENCE
Session 3, two weeks later: Visit with physician, 15 minutes
AND ABUSE
Follow-up and reinforcement
A formal diagnosis of alcoholism can have Session 4, two weeks later: Clinic nurse, via telephone
enormous personal implications for a Follow-up and reinforcement
patient, therefore assessment should be
detailed (Table 6).1
Alcohol abuse and dependence have a vari- FIGURE 2. Brief interventions for problem drinking in a primary care
able course characterized by periods of remis- setting.
sion and relapse. There are three major hurdles Information from Fleming M, Manwell LB. Brief intervention in primary care set-
tings. A primary treatment method for at-risk, problem, and dependent drinkers.
to overcome in the treatment of alcoholism:
Alcohol Res Health 1999;23:128-37, and Fleming MF, Barry KL, Manwell LB,
(a) physiologic dependence (symptoms of Johnson K, London R. Brief physician advice for problem alcohol drinkers. A ran-
withdrawal), (b) psychologic dependence domized controlled trial in community-based primary care practices. JAMA
(alcohol used as treatment for anxiety, de- 1997;277:1039-45.
TABLE 6
Synopsis of Diagnostic Criteria for Alcohol Abuse and Dependence
FEBRUARY 1, 2002 / VOLUME 65, NUMBER 3 www.aafp.org/afp AMERICAN FAMILY PHYSICIAN 445
life-threatening symptoms or have serious
Acamprosate, now being tested in the United States, medical conditions, suicidal or homicidal ten-
appears to be safe and well tolerated and may almost dou- dencies, disruptive family or job situations, or
are unable to attend outpatient facilities.23
ble the abstinence rate among recovering alcoholics.
SUSTAINED TREATMENT: LONG-TERM
MAINTENANCE OF ABSTINENCE
pression, stress), and (c) habit (the central part Considerable evidence shows that long-
that alcohol occupies in the framework of daily lasting neurobiologic changes in the brains of
living). alcoholics contribute to the persistence of
Alcohol dependence is treated in two craving. At any stage during recovery, relapse
stages: withdrawal and detoxification, fol- can be triggered by internal factors (depres-
lowed by further interventions to maintain sion, anxiety, craving for alcohol) or external
abstinence. factors (environmental triggers, social pres-
sures, negative life events).23 Psychosocial
IMMEDIATE TREATMENT: DETOXIFICATION treatments concentrate on helping patients to
The severity of withdrawal symptoms understand, anticipate, and prevent relapse.
increases with each withdrawal episode.
Severe withdrawal (grand mal convulsions, BEHAVIORAL TREATMENT APPROACHES
delirium tremens) occurs in 2 to 5 percent of Alcoholics Anonymous (AA) and 12-Step
heavy drinking, chronic alcoholics fewer than Facilitation Therapy. AA and similar self-help
three days after stopping alcohol consump- groups follow 12 steps that alcoholics
tion, and may last for three to seven days. should work through during recovery. This
With treatment, mortality is about 1 percent; free program is particularly supportive for
death is usually caused by cardiovascular col- those who are poor, isolated, lonely, or who
lapse or concurrent infection. come from a heavy-drinking social back-
Withdrawal severity and indications for ground. Twelve-Step Facilitation (TSF) is a
pharmacotherapy can be assessed by the formal treatment approach incorporating
revised Clinical Institute Withdrawal Assess- AA and similar 12-step programs.24
ment for Alcohol (CIWA-Ar) instrument.22 Cognitive-Behavior Therapy (CBT). The
Use of benzodiazepines greatly reduces the risk aim of CBT is to teach patients, by role-play
of seizure and symptoms of withdrawal. Alco- and rehearsal, to recognize and cope with
holics should be admitted to the hospital for high-risk situations for relapse, and to recog-
detoxification if they are likely to have severe, nize and cope with craving.25
Motivational Enhancement Therapy (MET).
This counseling method is used to motivate
Authors patients to use their own resources to change
their behavior.26
MARY-ANNE ENOCH, M.D., M.R.C.G.P., is currently a staff scientist at the Laboratory of
Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Md. Dr. Results of a large multisite study, Project
Enoch graduated from University College Hospital Medical School, London, England. MATCH,27 found that there was no differ-
DAVID GOLDMAN, M.D., is the chief of the Laboratory of Neurogenetics, National ence in the efficacy of CBT, MET, and TSF
Institute on Alcohol Abuse and Alcoholism, as well as an adjunct professor in the during the year following treatment, how-
department of biologic sciences, George Washington University, Washington D.C. Dr. ever, MET was found to be most effective in
Goldman graduated from the University of Texas Medical School, Houston.
those patients with high levels of anger, and
Address correspondence to Mary-Anne Enoch, M.D., M.R.C.G.P., NIH/ TSF and AA involvement was particularly
NIAAA/DICBR/LNG, 12420 Parklawn Dr., Park Bldg. 5, Rm. 451, MSC 8110, Bethesda,
MD 20892-8110 (e-mail: maenoch@niaaa.nih.gov). Reprints are not available from effective in patients from a heavy drinking
the authors. social environment.27
446 AMERICAN FAMILY PHYSICIAN www.aafp.org/afp VOLUME 65, NUMBER 3 / FEBRUARY 1, 2002
Problem Drinking and Alcoholism
FEBRUARY 1, 2002 / VOLUME 65, NUMBER 3 www.aafp.org/afp AMERICAN FAMILY PHYSICIAN 447
Problem Drinking and Alcoholism
10. Jacobson JL, Jacobson SW. Drinking moderately revised clinical institute withdrawal assessment
and pregnancy. Effects on child development. for alcohol scale (CIWA-Ar). Br J Addict 1989;84:
Alcohol Res Health 1999;23:25-30. 1353-7.
11. 10th special report to the U.S. Congress on alcohol 23. Fuller RK, Hiller-Sturmhofel S. Alcoholism treat-
and health: highlights from current research from ment in the United States. An overview. Alcohol
the Secretary of Health and Human Services. U.S. Res Health 1999;23:69-77.
Dept. of Health and Human Services, Public Health 24. Humphreys K. Professional interventions that facil-
Service, National Institutes of Health, National Insti- itate 12-step self-help group involvement. Alcohol
tute on Alcohol Abuse and Alcoholism 2000:429- Res Health 1999;23:93-8.
30; NIH publication no. 00-1583. 25. Longabaugh R, Morgenstern J. Cognitive-behav-
12. Cherpitel CJ. Brief screening instruments for alco- ioral coping-skills therapy for alcohol dependence.
holism. Alcohol Health Res World 1997;21:348-51. Current status and future directions. Alcohol Res
13. Saunders JB, Aasland OG, Babor TF, de la Fuente Health 1999;23:78-85.
JR, Grant M. Development of the Alcohol Use Dis- 26. DiClemente CC, Bellino LE, Neavins TM. Motiva-
orders Identification Test (AUDIT): WHO Collabora- tion for change and alcoholism treatment. Alcohol
tive Project On Early Detection Of Persons With Res Health 1999;23:86-92.
Harmful Alcohol Consumption—II. Addiction 27. Project MATCH secondary a priori hypotheses. Pro-
1993;88:791-804. ject MATCH Research Group. Addiction 1997;92:
14. Fiellin DA, Reid MC, O’Connor PG. Screening for 1671-98.
alcohol problems in primary care: a systematic 28. Finney JW, Hahn AC, Moos RH. The effectiveness
review. Arch Intern Med 2000;160:1977-89. of inpatient and outpatient alcohol abuse: the
15. U.S. Dept. of Health and Human Services, Public need to focus on mediators and moderators of set-
Health Service, National Institutes of Health, ting effects. Addiction 1996;91:1773-96.
National Institute on Alcohol Abuse and Alcoholism. 29. O’Malley SS. Opioid antagonists in the treatment
The physicians’ guide to helping patients with alco- of alcohol dependence: clinical efficacy and pre-
hol problems. Bethesda, Md.: National Institutes of vention of relapse. Alcohol Alcohol Suppl 1996;
Health, 1995; NIH publication no. 95-3769. 1:77-81.
16. Ewing JA. Detecting alcoholism. The CAGE ques- 30. Anton RF, Moak DH, Waid LR, Latham PK, Malcolm
tionnaire. JAMA 1984;252:1905-7. RJ, Dias JK. Naltrexone and cognitive behavioral
17. Cherpitel CJ. Analysis of cut points for screening therapy for the treatment of outpatient alcoholics:
instruments for alcohol problems in the emergency results of a placebo-controlled trial. Am J Psychia-
room. J Stud Alcohol 1995;56:695-700. try 1999;156:1758-64.
18. Fleming M, Manwell LB. Brief intervention in pri- 31. Kranzler H, Tennen H, Armeli S, Blomqvist O, Mod-
mary care settings. A primary treatment method esta V, Oncken C, et al. Targeted naltrexone for
for at-risk, problem, and dependent drinkers. Alco- early problem drinkers. 2001 Scientific Meeting of
hol Res Health 1999;23:128-37. the Research Society on Alcoholism. June 22-28,
19. Fleming MF, Barry KL, Manwell LB, Johnson K, Lon- 2001, Montreal, Quebec, Canada. Alcohol Clin Exp
don R. Brief physician advice for problem alcohol Res 2001;25(5 suppl):144A.
drinkers. A randomized controlled trial in commu- 32. Sass H, Soyka M, Mann K, Zieglgansberger W.
nity-based primary care practices. JAMA 1997; Relapse prevention by acamprosate. Results from a
277:1039-45. placebo-controlled study on alcohol dependence.
20. Ockene JK, Adams A, Hurley TG, Wheeler EV, Arch Gen Psychiatry 1996;53:673-80.
Hebert JR. Brief physician- and nurse practitioner- 33. Chick J. Safety issues concerning the use of disulfi-
delivered counseling for high-risk drinkers: does it ram in treating alcohol dependence. Drug Saf
work? Arch Intern Med 1999;159:2198-205. 1999;20:427-35.
21. National Institute on Alcohol Abuse and Alco- 34. Chick J, Gough K, Falkowski W, Kershaw P, Hore B,
holism. Brief intervention for alcohol problems. Mehta B, et al. Disulfiram treatment of alcoholism.
Alcohol alert no. 43, 1999. Retrieved October Br J Psychiatry 1992;161:84-9.
2001, from: http://www.niaaa.nih.gov/publications/ 35. Cornelius JR, Salloum IM, Ehler JG, Jarrett PJ, Cor-
alalerts.htm. nelius MD, Perel JM, et al. Fluoxetine in depressed
22. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, alcoholics. A double-blind, placebo-controlled trial.
Sellers EM. Assessment of alcohol withdrawal: the Arch Gen Psychiatry 1997;54:700-5.
448 AMERICAN FAMILY PHYSICIAN www.aafp.org/afp VOLUME 65, NUMBER 3 / FEBRUARY 1, 2002